{"id":"https://openalex.org/W3096332016","doi":"https://doi.org/10.1182/blood-2020-140490","title":"Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19","display_name":"Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3096332016","doi":"https://doi.org/10.1182/blood-2020-140490","mag":"3096332016"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-140490","doi":"https://doi.org/10.1182/blood-2020-140490","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-140490","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330271","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019869101","display_name":"Spyridoula Vasileiou","orcid":"https://orcid.org/0000-0002-7970-9391","observed_orcids":["https://orcid.org/0000-0002-7970-9391"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spyridoula Vasileiou","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033458386","display_name":"Manik Kuvalekar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manik Kuvalekar","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033931027","display_name":"Aster G. Workineh","orcid":"https://orcid.org/0000-0001-5976-3254","observed_orcids":["https://orcid.org/0000-0001-5976-3254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aster Workineh","raw_affiliation_strings":["AlloVir, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AlloVir, Houston, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055490098","display_name":"Ayumi Watanabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayumi Watanabe","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052253685","display_name":"Yovana Velazquez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yovana Velazquez","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070595408","display_name":"Suhasini D. Lulla","orcid":"https://orcid.org/0000-0002-7739-2589","observed_orcids":["https://orcid.org/0000-0002-7739-2589"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suhasini Lulla","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021029688","display_name":"Helen Elisabeth Heslop","orcid":"https://orcid.org/0000-0001-7049-7698","observed_orcids":["https://orcid.org/0000-0001-7049-7698"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen E. Heslop","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090351322","display_name":"Kimberly Mooney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Mooney","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087747792","display_name":"Kevin A. Grimes","orcid":"https://orcid.org/0000-0002-6190-0497","observed_orcids":["https://orcid.org/0000-0002-6190-0497"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Grimes","raw_affiliation_strings":["Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087049880","display_name":"George Carrum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Carrum","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053910362","display_name":"LaQuisa Chimere Hill","orcid":"https://orcid.org/0000-0003-4304-935X","observed_orcids":["https://orcid.org/0000-0003-4304-935X"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LaQuisa C. Hill","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058005688","display_name":"Premal Lulla","orcid":"https://orcid.org/0000-0002-7707-2331","observed_orcids":["https://orcid.org/0000-0002-7707-2331"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Premal Lulla","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020956671","display_name":"Ann Marie Leen","orcid":"https://orcid.org/0000-0002-4470-1760","observed_orcids":["https://orcid.org/0000-0002-4470-1760"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann M. Leen","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"5","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6371999979019165,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6371999979019165,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.2079000025987625,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.042100001126527786,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9089999794960022},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9549999833106995},{"id":"https://openalex.org/keywords/allogeneic-t-cell-therapy","display_name":"allogeneic T cell therapy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/virus-specific-t-cells","display_name":"virus-specific T cells","score":0.7730000019073486},{"id":"https://openalex.org/keywords/ex-vivo-t-cell-expansion","display_name":"ex vivo T cell expansion","score":0.7789999842643738},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplant-recipients","display_name":"hematopoietic stem cell transplant recipients","score":0.7889999747276306},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.9729999899864197},{"id":"https://openalex.org/keywords/immunogenic-peptides","display_name":"immunogenic peptides","score":0.4300000071525574},{"id":"https://openalex.org/keywords/t-cell-epitopes","display_name":"T cell epitopes","score":0.5019999742507935},{"id":"https://openalex.org/keywords/convalescent-donors","display_name":"convalescent donors","score":0.5400000214576721},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.6520000100135803},{"id":"https://openalex.org/keywords/severe-covid-19","display_name":"severe COVID-19","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7850154638290405},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.561895489692688},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.48689284920692444},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48027825355529785},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.44984978437423706},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4249504804611206},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33552518486976624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33301860094070435},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.11196660995483398},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2020-140490","doi":"https://doi.org/10.1182/blood-2020-140490","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-140490","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8330271","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330271","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8330271","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330271","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308873523","https://openalex.org/W3128151021","https://openalex.org/W4411224261","https://openalex.org/W4200149281","https://openalex.org/W4397043304","https://openalex.org/W3216035443","https://openalex.org/W4366463615","https://openalex.org/W3158195944","https://openalex.org/W4385667612","https://openalex.org/W3202877243"],"abstract_inverted_index":{"Background.":[0],"On":[1],"11":[2],"March,":[3],"2020":[4],"the":[5,24,33,108,135,157,171,179,183,198,282,382,407,422,437,465,479,508,571,585],"World":[6],"Health":[7],"Organization":[8],"declared":[9],"COVID-19,":[10],"caused":[11],"by":[12,23,379,460,470,496],"SARS-CoV-2,":[13],"a":[14,152,202,307,332,353,368,490,576],"global":[15],"pandemic":[16],"with":[17,56,83,114,124,223,240,313,321,352,371,399,520,549],"almost":[18,344],"17,000,000":[19],"confirmed":[20],"cases":[21],"worldwide":[22],"end":[25],"of":[26,28,37,60,111,141,159,173,182,187,200,213,262,326,339,346,355,381,391,410,421,481,555,587,658,676,687,705,723],"July,":[27],"which":[29,263],"4,500,000":[30],"were":[31,287,342,511],"in":[32,88,122,167,306,310,575,590,650,668,697,715],"US.":[34],"Approximately":[35],"20%":[36,97],"patients":[38,91,222,594],"develop":[39],"severe":[40,125,214,588],"disease":[41,216,589],"that":[42,341],"can":[43],"evolve":[44],"into":[45],"acute":[46],"respiratory":[47,52],"distress":[48],"syndrome":[49],"leading":[50],"to":[51,62,196,207,316,433,513,544,570,583],"or":[53,175,402,552,599,660,678,689,707,725],"multiorgan":[54],"failure,":[55],"an":[57,416,427,655,673,684,702,720],"overall":[58],"mortality":[59,92],"up":[61],"4%.":[63],"Older":[64],"age,":[65],"comorbidities":[66],"such":[67,595],"as":[68,78,94,96,151,289,377,426,494,596],"hypertension":[69],"and":[70,72,117,138,164,178,190,230,258,271,281,291,304,359,374,387,389,394,429,455,473,478,502,526,541,559],"diabetes,":[71],"immune":[73,466],"compromise":[74],"have":[75,98],"been":[76,99],"identified":[77,288],"major":[79],"risk":[80,212,592],"factors":[81],"associated":[82],"poor":[84],"prognosis.":[85],"For":[86],"example,":[87],"immunocompromised":[89,168],"HSCT":[90,218],"rates":[93],"high":[95,591],"reported":[100],"(www.cibmtr.org/COVID19).":[101],"Furthermore,":[102],"there":[103],"is":[104],"accumulating":[105],"evidence":[106,181],"regarding":[107],"protective":[109,185,231],"role":[110,186],"T":[112,148,192,247,319,348,363,475,608],"cells,":[113,193],"reduced":[115],"counts":[116],"dysregulation":[118],"seen":[119],"more":[120],"prominently":[121],"individuals":[123,239,537],"rather":[126],"than":[127],"mild":[128,241],"COVID-19.":[129],"Our":[130],"group":[131],"has":[132],"previously":[133],"demonstrated":[134,459],"feasibility,":[136],"safety":[137,560],"clinical":[139,562,578],"efficacy":[140],"administering":[142],"allogeneic":[143,527],"ex":[144],"vivo":[145],"expanded":[146,412,509],"multivirus-specific":[147],"cells":[149,320,340,349,366,413,483,488,510,609],"(multi-VSTs)":[150],"banked,":[153,203],"off-the-shelf":[154],"product":[155,206,569],"for":[156,246,293,561,573,601],"treatment":[158],"EBV,":[160],"CMV,":[161],"BKV,":[162],"HHV6":[163],"AdV":[165],"infections/disease":[166],"individuals.":[169],"Given":[170],"lack":[172],"preventative":[174],"therapeutic":[176],"agents":[177],"emerging":[180],"pivotal":[184],"SARS-CoV-2-specific":[188,204,318],"CD4+":[189,472],"CD8+":[191,474],"we":[194,234,414],"sought":[195],"explore":[197],"feasibility":[199],"developing":[201],"VST":[205,294,301],"treat":[208],"those":[209,597],"at":[210],"highest":[211],"COVID-19":[215,242],"(i.e.":[217],"recipients,":[219],"elderly":[220],"individuals,":[221],"comorbidities).":[224],"Methods.":[225],"To":[226,405],"first":[227],"identify":[228],"immunogenic":[229],"SARS-CoV-2":[232,260,532,606],"antigens":[233,425,439],"screened":[235],"PBMCs":[236],"from":[237,535],"convalescent":[238,536],"(not":[243],"requiring":[244],"hospitalization)":[245],"cell":[248,476],"activity":[249,322,409,522],"against":[250,323,436,523,614],"overlapping":[251],"peptide":[252],"libraries":[253],"(pepmixes)":[254],"spanning":[255],"18":[256],"structural":[257],"non-structural":[259,274],"proteins":[261,275],"8":[264],"[structural":[265],"proteins:":[266],"Spike":[267],"(S),":[268],"Membrane":[269],"(M)":[270],"Nucleoprotein":[272],"(N);":[273],"(Nsps):":[276],"3,":[277],"4,":[278],"6,":[279],"12;":[280],"accessory":[283],"protein":[284,504],"(AP)":[285],"7a]":[286],"immunodominant":[290,327],"advanced":[292],"manufacturing.":[295],"We":[296,330,564],"subsequently":[297],"utilized":[298],"our":[299,411],"optimized":[300],"manufacturing":[302],"process":[303],"culture":[305],"G-Rex":[308],"device":[309],"medium":[311],"supplemented":[312],"activating":[314],"cytokines":[315],"generate":[317],"this":[324,568],"combination":[325],"targets.":[328,617],"Results.":[329],"achieved":[331],"mean":[333],"29\u00b17":[334],"fold":[335],"expansion":[336],"(mean\u00b1SEM;":[337],"n=5)":[338],"comprised":[343],"exclusively":[345],"CD3+":[347],"(97.1\u00b10.7%;":[350],"mean\u00b1SEM),":[351],"mixture":[354],"cytotoxic":[356],"(CD8+;":[357],"10.2\u00b11.2%)":[358],"helper":[360],"(CD4+;":[361],"85.5\u00b11.8%)":[362],"cells.":[364],"These":[365],"had":[367],"phenotype":[369],"consistent":[370],"effector":[372,395],"function":[373],"memory":[375,396],"potential,":[376],"evidenced":[378],"upregulation":[380],"activation":[383],"markers":[384,397],"CD25,":[385],"CD69,":[386],"CD28":[388],"expression":[390],"central":[392],"(CD45RO+/CD62L+)":[393],"(CD45RO+/CD62L\u2212),":[398],"minimal":[400],"PD1":[401],"Tim3":[403],"expression.":[404],"confirm":[406],"anti-viral":[408],"performed":[415],"IFN\u03b3":[417],"ELIspot":[418],"using":[419],"each":[420],"individual":[423],"stimulating":[424],"immunogen":[428],"all":[430],"lines":[431],"proved":[432],"be":[434],"reactive":[435],"target":[438],"[S:":[440],"2,118\u00b1479":[441],"SFC/2x105;":[442],"M:":[443],"1,084\u00b1182;":[444],"N:":[445],"1,124\u00b1335;":[446],"Nsp3:":[447],"71\u00b148.6;":[448],"Nsp4:":[449],"68\u00b130;":[450],"Nsp6:":[451],"23\u00b16.7;":[452],"AP7a:":[453],"65\u00b143;":[454],"Nsp12:":[456],"29\u00b19].":[457],"As":[458],"intracellular":[461],"cytokine":[462],"staining":[463],"(ICS),":[464],"response":[467],"was":[468],"mediated":[469],"both":[471,556],"subsets,":[477],"majority":[480],"IFNg-producing":[482],"also":[484],"produced":[485],"TNFa.":[486],"Reactive":[487],"exhibited":[489],"primarily":[491],"Th1-polarized":[492],"profile":[493],"measured":[495],"Granzyme":[497],"B":[498],"production,":[499],"luminex":[500],"array":[501],"single-cell":[503],"analysis.":[505],"In":[506],"addition,":[507],"able":[512,543],"kill":[514,545],"viral":[515,546,615],"pepmix-loaded":[516],"autologous":[517,525],"PHA":[518],"blasts":[519],"minimal/no":[521],"non-antigen-expressing":[524],"targets":[528,548],"(Figure":[529],"1).":[530],"Conclusion.":[531],"VSTs":[533],"generated":[534],"are":[538,565],"Th1-polarized,":[539],"polyfunctional":[540],"selectively":[542],"antigen-expressing":[547,616],"no":[550],"auto-":[551],"alloreactivity,":[553],"indicative":[554],"their":[557],"selectivity":[558],"use.":[563],"rapidly":[566],"advancing":[567],"clinic":[572],"administration":[574],"randomized":[577],"trial":[579],"(VSTs+SOC":[580],"vs":[581],"SOC)":[582],"prevent":[584],"development":[586],"hospitalized":[593],"post-transplant":[598],"therapy":[600],"hematologic":[602],"malignancy.":[603],"Figure":[604,618],"1:":[605],"Specific":[607],"Demonstrate":[610],"Selective":[611],"Cytolytic":[612],"Activity":[613],"1":[619],"Disclosures":[620],"Vasileiou:":[621],"AlloVir:":[622,646],"Consultancy.":[623,625,630],"Kuvalekar:AlloVir:":[624],"Workineh:AlloVir:":[626],"Current":[627,647,665,694,712],"Employment.":[628],"Watanabe:AlloVir:":[629],"Heslop:Novartis:":[631],"Consultancy;":[632,635,638,640],"Gilead":[633],"Biosciences:":[634],"PACT":[636],"Pharma:":[637],"Kiadis:":[639],"Tessa":[641],"Therapeutics:":[642,664,711],"Consultancy,":[643,693],"Research":[644],"Funding;":[645],"equity":[648,666,695,713],"holder":[649,667,696,714],"publicly-traded":[651,669,698,716],"company,":[652,670,699,717],"Membership":[653,671,682,700,718],"on":[654,672,683,701,719],"entity's":[656,674,685,703,721],"Board":[657,675,686,704,722],"Directors":[659,677,688,706,724],"advisory":[661,679,690,708,726],"committees;":[662,709],"Marker":[663,710],"committees.":[680,691,727],"Hill:Incyte:":[681],"Leen:AlloVir:":[692]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-11-09T00:00:00"}
